GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
MAKO SURGICAL CORP (MAKO) [hlAlert]

Rating:
Outperform
MAKO
up 179.49 %

MAKO SURGICAL CORP (MAKO) rated Outperform by Cowen & Co

Posted on: Wednesday,  Mar 26, 2008  8:25 AM ET by Cowen & Co

Cowen & Co rated Outperform MAKO SURGICAL CORP (NASDAQ: MAKO) on 03/26/2008, when the stock price was $10.73.
Since then, MAKO SURGICAL CORP has gained 179.50% as of 12/16/2013's recent price of $29.99.
If you would have followed this Cowen & Co's recommendation on MAKO, you would have gained 179.49% of your investment in 2091 days.

MAKO Surgical Corp. (MAKO) is a medical device company that markets its robotic arm solution and orthopedic implants for minimally invasive orthopedic knee procedures. MAKO offers MAKOplasty, a restorative surgical solution that enables orthopedic surgeons to treat patient specific, early to mid-stage osteoarthritic knee disease. Its robotic arm systems, branded as its first generation Tactile Guidance System (TGS), and its second generation RIO Robotic Arm Interactive Orthopedic system (RIO), utilize tactile guided robotic arm technology and patient specific visualization to prepare the knee joint for the insertion and alignment of its resurfacing implants through a small incision in a minimally invasive, bone preserving and tissue sparing procedure. MAKO has an intellectual property portfolio of more than 250 licensed or owned patents and patent applications relating to the areas of computer assisted surgery, robotics, haptics and implants.

Cowen and Company’s culture is rooted in the traditions of the research boutiques that once dominated the investment research landscape. Our primary focus is on two products: 1. Proprietary information flow, and 2. Good investment ideas We achieve the first objective with a combination of extensive primary research work, organized survey activity, and access to industry experts (i.e., opinion leaders in medicine, technology, and consumer industries). We believe that the best investment idea is a “Correct Non-Consensus Conclusion,” and a considerable amount of our energy is devoted to this pursuit. We spend as little time as possible on traditional maintenance research products.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/26/2008 8:25 AM Buy
None
10.73
as of 12/24/2008
1 Week down  -1.71 %
1 Month down  -7.39 %
3 Months up  0.73 %
1 YTD up  3.14 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy